Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rao N V S Mamidi

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Biomedical Chromatography : BMC|July 29, 2003
Bioanalytical considerations for compounds containing free sulfhydryl groupsNuggehally R Srinivas, Rao N V S Mamidi
Biomedical Chromatography : BMC|December 11, 2002
Quantitative determination of ragaglitazar in rat plasma by HPLC: validation and application in pharmacokinetic studyJagannath Kota, Ramesh Mullangi, Rao N V S Mamidi, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 9, 2002
Oral bioavailability and pharmacokinetics of PAT-5A, a new insulin sensitizer in ratsRao N V S Mamidi, Kasiram Katneni, Ramesh Mullangi, et al.
Biomedical Chromatography : BMC|September 19, 2003
Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standardRao N V S Mamidi, Biju Benjamin, Mullangi Ramesh, et al.
Biomedical Chromatography : BMC|September 19, 2003
Quantitative determination of DRF-1042 in human plasma by HPLC: validation and application in clinical pharmacokineticsVijay V Upreti, Rao N V S Mamidi, Kasiram Katneni, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Cell-based models to study hepatic drug metabolism and enzyme induction in humansMarc Vermeir, Pieter Annaert, Rao N V S Mamidi, et al.
Biomedical Chromatography : BMC|September 24, 2004
Determination of lipoic acid in rat plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a pharamcokinetic studyRavi Kumar Trivedi, Raja Reddy Kallem, Rao N V S Mamidi, et al.
Biomedical Chromatography : BMC|September 24, 2004
HPLC method for determination of DRF-4367 in rat plasma: validation and its application to pharmacokinetics in Wistar ratsRamesh Mullangi, Raja Reddy Kallem, Ravi Kanth Bhamidipati, et al.
Journal of Clinical Pharmacology|April 2, 2015
In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humansStephan Francke, Rao N V S Mamidi, Bhavna Solanki, et al.
Toxicologic Pathology|November 16, 2014
Successful integration of nonclinical and clinical findings in interpreting the clinical relevance of rodent neoplasia with a new chemical entityKirk Ways, Mark D Johnson, Rao N V S Mamidi, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Biomedical Chromatography : BMC|July 29, 2003
Bioanalytical considerations for compounds containing free sulfhydryl groupsNuggehally R Srinivas, Rao N V S Mamidi
Biomedical Chromatography : BMC|December 11, 2002
Quantitative determination of ragaglitazar in rat plasma by HPLC: validation and application in pharmacokinetic studyJagannath Kota, Ramesh Mullangi, Rao N V S Mamidi, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 9, 2002
Oral bioavailability and pharmacokinetics of PAT-5A, a new insulin sensitizer in ratsRao N V S Mamidi, Kasiram Katneni, Ramesh Mullangi, et al.
Biomedical Chromatography : BMC|September 19, 2003
Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standardRao N V S Mamidi, Biju Benjamin, Mullangi Ramesh, et al.
Biomedical Chromatography : BMC|September 19, 2003
Quantitative determination of DRF-1042 in human plasma by HPLC: validation and application in clinical pharmacokineticsVijay V Upreti, Rao N V S Mamidi, Kasiram Katneni, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Cell-based models to study hepatic drug metabolism and enzyme induction in humansMarc Vermeir, Pieter Annaert, Rao N V S Mamidi, et al.
Biomedical Chromatography : BMC|September 24, 2004
Determination of lipoic acid in rat plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a pharamcokinetic studyRavi Kumar Trivedi, Raja Reddy Kallem, Rao N V S Mamidi, et al.
Biomedical Chromatography : BMC|September 24, 2004
HPLC method for determination of DRF-4367 in rat plasma: validation and its application to pharmacokinetics in Wistar ratsRamesh Mullangi, Raja Reddy Kallem, Ravi Kanth Bhamidipati, et al.
Journal of Clinical Pharmacology|April 2, 2015
In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humansStephan Francke, Rao N V S Mamidi, Bhavna Solanki, et al.
Toxicologic Pathology|November 16, 2014
Successful integration of nonclinical and clinical findings in interpreting the clinical relevance of rodent neoplasia with a new chemical entityKirk Ways, Mark D Johnson, Rao N V S Mamidi, et al.
Pageof 4